CORCEPT THERAPEUTICS INC — Director's Dealing 2017

Jul 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2017-07-12

Reporting Person: MAHONEY DAVID L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-12	Common Stock	S	6510	$12.50	Disposed	1129163	Indirect
2017-07-13	Common Stock	S	484	$12.548	Disposed	1128679	Indirect

Footnotes

F1: The sale is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares.

F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $12.52 to $12.56 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.